Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07585630 · ClinicalTrials.gov registry record · Phase 2
A1Cantus vs. Placebo
A Phase 2 study, sponsored by University of California, Riverside.
- Not yet
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT07585630 is a Phase 2 study that has not yet begun recruiting, run by University of California, Riverside. The registered enrollment target is 50 participants.
The verdict
NCT07585630, a Phase 2 study, has not yet begun recruiting, sponsored by University of California, Riverside.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
The investigators will conduct a randomized controlled 2-arm parallel trial of A1c Drink vs. Placebo over a 3-month period and compare changes in Ha1c from baseline to 3 months. Investigator and study personnel, as well as participants, will be blinded to drink assignments.
Interventions
- OTHER Placebo drink
- DIETARY_SUPPLEMENT A1C Drink
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2028-06-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07585630
The ClinicalTrials.gov registry entry for NCT07585630 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Riverside, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo drink is the first listed.
NCT07585630 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07585630 about?
NCT07585630 is a clinical study titled "A1Cantus vs. Placebo". The investigators will conduct a randomized controlled 2-arm parallel trial of A1c Drink vs. Placebo over a 3-month period and compare changes in Ha1c from baseline to 3 months. Investigator and study personnel, as well as participants, will be blinded to drink assignments.
What is the current status of trial NCT07585630?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2026-06-15. Estimated completion is 2028-06-01.
What interventions are being tested in trial NCT07585630?
The interventions under investigation include: Placebo drink (OTHER), A1C Drink (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07585630?
This trial is sponsored by University of California, Riverside, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.